Steph Spanos News Today

/PRNewswire/ -- Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded $1.3 million to 23 organizations...

The news comes just six months after the Madison-based company’s last layoffs. Its revenues are growing and losses shrinking, but it’s yet to turn a profit.

ADAPT Triad minimal residual disease analysis study intended to evaluate the association between circulating tumor DNA (ctDNA) positivity and recurrence intervals MADISON, Wis., Aug. 3

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, announced today that it has entered a collaboration agreement with...

/PRNewswire/ -- PreventionGenetics, a subsidiary of Exact Sciences Corp., announced today that it was recently granted marketing authorization for the...

Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope Talented team and industry-leading lab will help strengthen the companys sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings News provided by Share this article (PRNewsfoto/EXACT SCIENCES CORP) (PRNewsfoto/EXACT SCIENCES CORP) MADISON, Wis., April 14, 2021 /PRNewswire/ -- Exact Sciences Corp. (NA...

Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hopes Genomics Institute, TGen Provides Access to Industry-Leading Sequencing Lab and Plans for 10-Year Partnership with National Cancer Research Leaders News provided by Share this article (PRNewsfoto/EXACT SCIENCES CORP) (PRNewsfoto/EXACT SCIENCES CORP) MADISON, Wis., Feb. 16, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has entered into an agreement to acquire Ashion...